Valneva SE (VALN) Other Working Capital Changes (2021 - 2026)

Valneva SE's (VALN) quarterly Other Working Capital Changes came in at -$801960.8 in Q1 2026, down 11.3% year-on-year from -$904125.5 in Q1 2025, and down 4.57% quarter-over-quarter from -$766900.1 in Q3 2025.

Valneva SE (VALN) Other Working Capital Changes (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Other Working Capital Changes across 6 years of filings, most recently posting -$801960.8 for Q1 2026.

  • Other Working Capital Changes for Q1 2026 came in at -$801960.8, down 11.3% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.1 million (down 5.0% YoY), and the FY2024 annual result was -$2.9 million, up 13.64% from the prior year.
  • Other Working Capital Changes came in at -$801960.8 for Q1 2026 at Valneva SE, down from -$766900.1 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.9 billion in Q3 2023 to a low of -$1.9 billion in Q2 2023.
  • The 5-year median for Other Working Capital Changes is -$753718.7 (2022), against an average of -$825700.5.
  • Peak annual rise in Other Working Capital Changes reached 292306.32% in 2023, while the deepest fall reached 255621.4% in 2023.
  • Valneva SE's Other Working Capital Changes stood at -$894756.9 in 2022, then climbed by 17.87% to -$734867.0 in 2023, then jumped by 110.03% to $73733.1 in 2024, then slumped by 1140.1% to -$766900.1 in 2025, then fell by 4.57% to -$801960.8 in 2026.
  • The last three Other Working Capital Changes figures came in at -$801960.8 (Q1 2026), -$766900.1 (Q3 2025), and -$791239.8 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -801,960.77
Mar 31, 2026 -801,960.77
Sep 30, 2025 -766,900.14
Sep 30, 2025 -766,900.14
Jun 30, 2025 -791,239.82
Jun 30, 2025 -791,239.82
Mar 31, 2025 -720,540.84
Mar 31, 2025 -720,540.84
Dec 31, 2024 73,733.08
Dec 31, 2024 73,733.08
Sep 30, 2024 -716,039.12
Sep 30, 2024 -716,039.12
Jun 30, 2024 -1.57 Mn
Jun 30, 2024 -1.57 Mn
Mar 31, 2024 -735,466.92
Mar 31, 2024 -735,466.92
Dec 31, 2023 -734,866.96
Dec 31, 2023 -734,866.96
Sep 30, 2023 1.89 Bn
Sep 30, 2023 1.89 Bn